Hippocampal plasticity during the progression of Alzheimer's disease

Neuroscience

Volumn 309, Issue , 2015, Pages 51-67

  Mufson, E J ^a   Mahady, L ^a   Waters, D ^a   Counts, S E ^b   Perez, S E ^c   DeKosky, S T ^d   Ginsberg, S D ^e   Ikonomovic, M D ^d   Scheff, S W ^f   Binder, L I ^b  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Degeneration; Hippocampus; Mild cognitive impairment; Neurotrophins; Plasticity

Indexed keywords

NEUROTROPHIN; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANATOMICAL CONCEPTS; ARTICLE; CHOLINERGIC SYSTEM; COGNITIVE RESERVE; HIPPOCAMPUS; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; PRIORITY JOURNAL; ANIMAL; COGNITIVE DEFECT; DISEASE COURSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE;

ALZHEIMER DISEASE; ANIMALS; COGNITIVE DYSFUNCTION; COGNITIVE RESERVE; DISEASE PROGRESSION; HIPPOCAMPUS; HUMANS; NERVE GROWTH FACTORS; NEURONAL PLASTICITY; SYNAPSES;

EID: 84945472037     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.03.006     Document Type: Article

References (234)

1. Adolfsson R., Gottfries C.G., Roos B.E., Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 1979, 135:216-223.
2. Altman J. Audioradiographic investigation of cell proliferation in the brains of rats and cats. Anat Rec 1963, 145:573-591.
3. Altman J. Audioradiographic and histological evidence of postnatal neurogenesis in rats. J Comp Neurol 1965, 124:319-335.
4. Alzheimer A. Über einen eigenartigen schweren Erkrankungsprozeß der Hirnrinde. Neurologisches Centralblatt 1906, 23:1129-1136.
5. Alzheimer A. Uber eigenartige Krankheitsfaelle des Spaetern Alters, Zeitschrift fuer die gesamte. Neurol Psych 1911, 4:256-286.
6. Amaral D, Lavenex P (2006), Hippocampal Neuroanatomy, in Andersen P, Morris R, Amaral D, Bliss T, O'Keefe J: The Hippocampus Book. Oxford University Press.
7. Arriagada P.V., Growdon J.H., Hedley-Whyte E.T., et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992, 42:631-639.
8. Baas P.W., Heidemann S.R. Microtubule reassembly from nucleating fragments during the regrowth of amputated neurites. J Cell Biol 1986, 104:917-927.
9. Berchtold N.C., Sabbagh M.N., Beach T.G., Kim R.C., Cribbs D.H., Cotman C.W. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease. Neurobiol Aging 2014, 35:1961-1972.
10. Bertoni-Fredarri C., Fattoretti P., Casoli T., Meier-Ruge W., Ulrich J. Morphological adaptive response of synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease. Brain Res 1990, 517:69-75.
11. Bierer L.M., Hof P.R., Purohit D.P., Carlin L., Schmeidler J., Davis K.L., Perl D.P. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995, 52:81-88.
12. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., Davis K.L. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem 1995, 64:749-760.
13. Bishop N.E. Dynamics of endosomal sorting. Int Rev Cytol 2003, 232:1-57.
14. Bowser R., Kordower J.H., Mufson E.J. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease. Brain Pathol 1997, 7:723-730.
15. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
16. Braak H., Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 2011, 121:171-181.
17. Bell K.F., Bennett D.A., Cuello A.C. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment. J Neurosci 2007, 27:10810-10817.
18. Cataldo A.M., Hamilton D.J., Nixon R.A. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 1994, 640:68-80.
19. Cataldo A.M., Barnett J.L., Berman S.A., Li J., Quarless S., Bursztajn S., et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 1995, 14:671-680.
20. Cataldo A.M., Hamilton D.J., Barnett J.L., Paskevich P.A., Nixon R.A. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 1996, 16:186-199.
21. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J Comp Neurol 1988, 273:543-557.
22. Chao M.V. Retrograde transport redux. Neuron 2003, 39:1-2.
23. Chapman P.F., White G.L., Jones M.W., et al. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 1999, 2:271-276.
24. Cotman C.W., Matthews D.A., Taylor D., Lynch G. Synaptic rearrangement in the dentate gyrus: histochemical evidence of adjustments after lesions in immature and adult rats. Proc Natl Acad Sci 1973, 70:3473-3477.
25. Cotman C.W., Lynch G.S. Reactive synaptogenesis in the adult nervous system. Neuronal recognition 1976, 69-108. Plenum, New York. S.H. Barondes (Ed.).
26. Cotman C.W., Scheff S.W. Compensatory synapse growth in aged animals after neuronal death. Mech Aging Dev 1979, 9:103-117.
27. Counts S.E., Perez S.E., Ginsberg S.D., De Lacalle S., Mufson E.J. Galanin in Alzheimer disease. Mol Interv 2003, 3:137-156.
28. (NTR) protein in early-stage Alzheimer's disease. Ann Neurol 2004, 56:520-531.
29. Counts S.E., Chen E.Y., Che S., Ikonomovic M.D., Wuu J., Ginsberg S.D., Dekosky S.T., Mufson E.J. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dement Geriatr Cogn Disord 2006, 21:205-214.
30. Counts S.E., He B., Che S., Ginsberg S.D., Mufson E.J. Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease. Neurodegener Dis 2008, 5:228-231.
31. Counts S.E., He B., Che S., Ginsberg S.D., Mufson E.J. Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease. J Alzheimers Dis 2009, 18:885-896.
32. Counts S.E., Perez S.E., Ginsberg S.D., Mufson E.J. Neuroprotective role for galanin in Alzheimer's disease. EXS 2010, 102:143-162.
33. Counts S.E., Mufson E.J. Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem 2010, 113:649-660.
34. Counts S.E., He B., Nadeem M., Wuu J., Mufson E.J. Hippocampal drebrin loss in mild cognitive impairment. Neurodeg Dis 2011, 10:216-219.
35. Counts S.E., Alldred M.J., Che S., Ginsberg S.D., Mufson E.J. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology 2014, 79:172-179.
36. Coumis U., Davies C.H. The effects of galanin on long-term synaptic plasticity in the CA1 area of rodent hippocampus. Neuroscience 2002, 112:173-182.
37. Cowburn R., Hardy J., Roberts P., Briggs R. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Neurosci Lett 1988, 86:109-113.
38. Cowburn R., Hardy J., Roberts P., Briggs R. Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease. Brain Res 1988, 452:403-407.
39. Crawley J.N. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sci 1996, 58:2185-2199.
40. Cross A.J., Slater P., Candy J.M., Perry E.K., Perry R.H. Glutamate deficits in Alzheimer's disease. J Neurosurg Psychiatry 1987, 50:357-358.
41. Danysz W., Parsons C.G. Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine - searching for the connections. Br J Pharmacol 2012, 167:324-352.
42. Dash P.K., Mach S.A., Moore A.N. Enhanced neurogenesis in the rodent hippocampus following traumatic brain injury. J Neurosci Res 2001, 63:313-319.
43. Davies P., Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2:1403.
44. Davis K.L., Mohs R.C., Marin D., et al. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 1999, 281:1401-1406.
45. Deinhardt K., Salinas S., Verastegui C., Watson R., Worth D., Hanrahan S., Bucci C., Schiavo G. Rab5 and rab7 control endocytic sorting along the axonal retrograde transport pathway. Neuron 2006, 52:293-305.
46. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 1990, 27:457-464.
47. DeKosky S.T., Ikonomovic M.D., Styren S.D., et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002, 51:145-155.
48. Dewar D., Chalmers D.T., Graham D.I., McCulloch J. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus. Brain Res 1991, 553:58-64.
49. Ding Q., Dimayuga E., Keller J.N. Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr Alzheimer Res 2007, 4:73-79.
50. Doetsch F., Caille I., Lim D.A., Garcia-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97:703-716.
51. Dunn W.A. Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J Cell Biol 1990, 110:1935-1945.
52. Dutar P., Lamour Y., Nicoll R.A. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur J Pharmacol 1989, 164:355-360.
53. Edwards R.H., Selby M.J., Mobley W.C., Weinrich S.L., Hruby D.E., Rutter W.J. Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia vector. Mol Cell Biol 1988, 8:2456-2464.
54. Ellison D.W., Beal M.F., Mazurek M.F., Bird E.D., Martin J.B. A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol 1986, 20:616-621.
55. Fahnestock M., Mchalski B., Xu B., Coughlin M.D. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001, 18:210-220.
56. Fifkova E. Two types of terminal degeneration in the molecular layer of the dentate fascia following lesions of the entorhinal cortex. Brain Res 1975, 96:169-175.
57. Fisone G., Wu C.F., Consolo S., Nordstrom O., Brynne N., Bartfai T., Melander T., Hokfelt T. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci U S A 1987, 84:7339-7343.
58. Francke U., de Martinville B., Coussens L., Ullrich A. The human gene for the beta subunit of nerve growth factor is located on the proximal short arm of chromosome 1. Science 1983, 222:1248-1251.
59. Gage F.H., Coates P.W., Palmer T.D., Kuhn H.G., Fisher L.J., Suhonen J.O., Peterson D.A., Suhr S.T., Ray J. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A 1995, 92:11879-11883.
60. Gao S., Hendrie H.C., Hall K.S., Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 1998, 55:809-815.
61. Garcia-Sierra F., Ghoshal N., Quinn B., Berry R.W., Binder L.I. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. J Alzheimers Dis 2003, 5:65-77.
62. Geddes J.W., Monaghan D.T., Cotman C.W., Lott I.T., Kim R.C., Chiu H.C. Plasticity of hippocampal circuitry in Alzheimer's disease. Science 1985, 230:1179-1181.
63. Geddes J.W., Chang-Chui H., Cooper S.M., Lott I.T., Cotman C.W. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res 1986, 399:156-161.
64. Geddes J.W., Anderson K.J., Cotman C.W. Senile plaques as aberrant sprout-stimulating structures. Exp Neurol 1986, 94:767-776.
65. George S., Mufson E.J., Leurgans S., Shah R.C., Ferrari C., Detoledo-Morrell L. MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD. Neurobiol Aging 2011, 32:1756-1764.
66. Giannakopoulos P., Herrmann F.R., Bussiere T., Bouras C., Kovari E., Perl D.P., Morrison J.H., Gold G., Hof P.R. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003, 60:1495-1500.
67. Gilmor M.L., Erickson J.D., Varoqui H., et al. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 1999, 411:693-704.
68. Ginsberg S.D., Alldred M.J., Counts S.E., et al. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry 2010, 68:885-893.
69. Ginsberg S.D., Mufson E.J., Counts S.E., Wuu J., Alldred M.J., Nixon R.A., Che S. Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 2010, 22:631-639.
70. Ginsberg S.D. Glutamatergic neurotransmission expression profiling in the mouse hippocampus after perforant-path transection. Am J Geriatr Psychiatry 2005, 13:1052-1061.
71. Ginsberg S.D., Hemby S.E., Lee V.M.Y., Eberwine J.H., Trojanowski J.Q. Expression profile of transcripts in Alzheimer's disease neurofibrillary tangle-bearing CA1 neurons identifies new potential mediators of neurodegeneration. Ann Neurol 2000, 48:77-87.
72. Ginsberg S.D., Elarova I., Ruben M., Tan F., Counts S.E., Eberwine J.H., Trojanowski J.Q., Hemby S.E., Mufson E.J., Che S. Single cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders. Neurochem Res 2004, 29:1053-1064.
73. Ginsberg S.D., Che S. Expression profile analysis within the human hippocampus: comparison of CA1 and CA3 pyramidal neurons. J Comp Neurol 2005, 487:107-118.
74. Ginsberg S.D., Che S., Counts S.E., Mufson E.J. Single cell gene expression profiling in Alzheimer's disease. NeuroRx 2006, 3:302-318.
75. Ginsberg S.D. Alterations in discrete glutamate receptor subunits in adult mouse dentate gyrus granule cells following perforant path transection. Anal Bioanal Chem 2010, 397:3349-3358.
76. Goekoop R., Scheltens P., Barkhof F., Rombouts S. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation - a pharmacological fMRI study. Brain 2006, 129:141-157.
77. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996, 16:4491-4500.
78. Gordon P.B., Hoyvik H., Seglen P.O. Prelysosomal and lysosomal connections between autophagy and endocytosis. Biochem J 1992, 283:361-369.
79. Gordon P.B., Seglen P.O. Prelysosomal convergence of autophagic and endocytic pathways. Biochem Biophys Res Commun 1988, 151:40-47.
80. Greenamyre J.T., Penney J.B., Young A.B., D'Amato C.J., Hicks S.P., Shoulson I. Alterations in l-glutamate binding in Alzheimer's and Huntington's diseases. Science 1985, 227:1496-1499.
81. 3H]glutamate binding. J Neurochem 1987, 48:543-551.
82. Grudzien A., Shaw P., Weintraub S., Bigio E., Mash D.C., Mesulam M.M. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 2007, 28:327-335.
83. Guillozet A.L., Weintraub S., Mash D.C., Mesulam M.M. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003, 60:729-736.
84. Haass C., Selkoe D.J. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 1993, 75:1039-1042.
85. Habert-Ortoli E., Amiranoff B., Loquet I., Laburthe M., Mayaux J.F. Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci U S A 1994, 91:9780-9783.
86. Hardy J., Cowburn R., Barton A., Reynolds G., Lofdahl E., O'Carroll A., Wester P., Winblad B. Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci Lett 1987, 73:77-80.
87. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991, 12:383-388.
88. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
89. Hartonian I., Mufson E.J., de Lacalle S. Long-term plastic changes in galanin innervation in the rat basal forebrain. Neuroscience 2002, 115:787-795.
90. Hatanpaa K., Isaacs K.R., Shirao T., Brady D.R., Rapoport S.I. Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. J Neuropathol Exp Neurol 1999, 58:637-643.
91. Hayashi K., Ishikawa R., Ye L.H., He X.L., Takata K., Kohama K., Shirao T. Modulatory role of drebrin on the cytoskeleton within dendritic spines in the rat cerebral cortex. J. Neurosci. 1996, 16:7161-7170.
92. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbral transections. J Neurosci 1986, 6:2155-2162.
93. Honer W.G., Barr A.M., Sawada K., Thornton A.E., Morris M.C., Leurgans S.E., Schneider J.A., et al. Cognitive reserve, presynaptic proteins and dementia in the elderly. Transl Psychiatry 2012, 2:1-8.
94. Hyman B.T., Van Hoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
95. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986, 20:472-481.
96. Hyman B.T., Van Hoesen G.W., Damasio A.R. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 1987, 22:37-40.
97. Hyman B.T., Kromer B.A., Van Hoesen G.W. Reinnervation of the hippocampus perforant pathway zone in Alzheimer's disease. Ann Neurol 1987, 21:259-267.
98. Hyman B.T., Van Hoesen G.W., Damasio A.R. Memory-related neural systems in Alzheimer's disease: an anatomic study. Neurology 1990, 40:1721-1730.
99. Ibanez C.F. Jekyll-Hyde neurotrophins: the story of proNGF. Trends Neurosci 2002, 25:284-286.
100. Ikonomovic M.D., Mizukami K., Davies P., Hamilton R., Sheffield R., Armstrong D.M. The loss of Glu R2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. J Neuropathol Exp Neurol 1997, 56:1018-1027.
101. Ikonomovic M.D., Mizukami K., Warde D., Sheffield R., Hamilton R., Wenthold R.J., Armstrong D.M. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease. Exp Neurol 1999, 160:194-204.
102. Ikonomovic M.D., Mufson E.J., Wuu J., et al. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis 2003, 5:39-48.
103. Ikonomovic M.D., Abrahamson E.E., Isanski B.A., Wuu J., Mufson E.J., DeKosky S.T. Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. Arch Neurol 2007, 64:1312-1317.
104. Iulita M.F., Do C.S., Ower A.K., Fortress A.M., Aguilar L.F., Hanna M., Wisniewski T., Granholm A.C., Buhusi M., Busciglio J., Cuello A.C. Nerve growth factor metabolic dysfunction in Down's syndrome brains. Brain 2014, 137:860-872.
105. Jellinger K.A., Attems J. Neuropathological approaches to cerebral aging and neuroplasticity. Dialogues Clin Neurosci 2013, 15:29-43.
106. Jhamandas J.H., Harris K.H., MacTavish D., Jassar B.S. Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease. J Neurophysiol 2002, 87:696-704.
107. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 2004, 101:343-347.
108. Johansson C.B., Svensson M., Wallstedt L., Janson A.M., Frisen J. Neural stem cells in the adult brain. Exp Cell Res 1999, 253:733-736.
109. Johnson E.M., Taniuchi M., Clark H.B., Springer J.E., Koh S., Tayrien M.W., Loy R. Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J Neurosci 1987, 7:923-929.
110. Johnson J.K., Pa J., Boxer A.L., et al. Baseline predictors of clinical progression among patients with dysexecutive mild cognitive impairment. Dement Geriatr Cogn Disord 2010, 30:344-351.
111. Kaplan D.R., Miller F.D. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000, 10:381-391.
112. Katzman R., Terry R., DeTeresa R., et al. Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988, 23:138-144.
113. Kennedy M.B., Beale H.C., Carlisle H.J., Washburn L.R. Integration of biochemical signalling in spines. Nat Rev Neurosci 2005, 6:423-434.
114. Kilimann I., Grothe M., Heinsen H., Alho E.J., Grinberg L., Amaro E., et al. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. J Alzheimers Dis 2014, 40:687-700.
115. Klink R., Alonso A. Morphological characteristics of layer II projection neurons in the rat medial entorhinal cortex. Hippocampus 1997, 7:571-583.
116. Koffie R.M., Meyer-Luehmann M., Hashimoto T., et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A 2009, 106:4012-4017.
117. Kolakowski L.F., O'Neill G.P., Howard A.D., Broussard S.R., Sullivan K.A., Feighner S.D., Sawzdargo M., Nguyen T., Kargman S., Shiao L.L., et al. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem 1998, 71:2239-2251.
118. Kordower J.H., Chu Y., Stebbins G.T., et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2000, 49:202-213.
119. Kuhn H.G., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 1996, 16(6):2027-2033.
120. Lacor P.N., Buniel M.C., Furlow P.W., Clemente A.S., Velasco P.T., Wood M., Viola K.L., Klein W.L. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 2007, 27:796-807.
121. LaVail J.H., LaVail M.M. Retrograde axonal transport in the central nervous system. Science 1974, 176:1416-1417.
122. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948.
123. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440:352-357.
124. Liu J., Lamb D., Chou M.M., Liu Y.J., Li G. Nerve growth factor-mediated neurite out growth via regulation of Rab5. Mol Biol Cell 2007, 18:1375-1384.
125. Lois C., Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci U S A 1993, 90:2074-2077.
126. Lorente de Nó R. Studies on the structure of the cerebral cortex. II. Continuation of the study of the Ammonic system. J Psychol Neurol 1934, 46:113-177.
127. Lovell M.A., Markesbery W.A. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 2007, 85:3036-3040.
128. Mann D.M., Yates P.O., Hawkes J. The pathology of the human locus ceruleus. Clin Neuropathol 1983, 2:1-7.
129. Mann D.M., Yates P.O. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders. Hum Neurobiol 1986, 5:147-158.
130. Markesbery W.R. Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 2010, 19:221.
131. Markesbery W.R., Schmitt F.A., Kryscio R.J., Davis D.G., Smith C.D., Wekstein D.R. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006, 63:38-46.
132. Masliah E., Fagan A.M., Terry R.D., DeTeresa R., Mallory M., Gage F.H. Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat. Exp Neurol 1991, 113:131-142.
133. Matthews D.A., Cotman C., Lynch G. An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and time course of degeneration. Brain Res 1976, 115:1-21.
134. Matthews D.A., Cotman C., Lynch G. An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. II. Reappearance of morphologically normal synaptic contacts. Brain Res 1976, 115:23-41.
135. Mawal-Dewan M., Henley J., Van de Voorde A., Trojanowski J.Q., Lee V.M.Y. The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J Biol Chem 1994, 269:30981-30987.
136. Mazarati A.M., Hohmann J.G., Bacon A., Liu H., Sankar R., Steiner R.A., Wynick D., Wasterlain C.G. Modulation of hippocampal excitability and seizures by galanin. J Neurosci 2000, 20:6276-6281.
137. McDonald M.P., Gleason T.C., Robinson J.K., Crawley J.N. Galanin inhibits performance on rodent memory tasks. Ann N Y Acad Sci 1998, 863:305-322.
138. McKhann G., Drachman D., Folstein M., Katzman R., Price D., et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
139. Mervis R.F., Patel C.J., Foley S.K., Zajd S., Aradi M., Solanki P., Walha G.S., Scheff S.E., Mufson E.J. Hippocampal CA1 dendritic neuroplasticity in mild cognitive impairment and Alzheimer's disease. Neuroscience 2013, Abstr.
140. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 1983, 214:170-197.
141. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 1999, 24:521.
142. Mesulam M., Shaw P., Mash D., Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 2004, 55:815-828.
143. 3H]TCP binding sites in Alzheimer's disease. Neurosci Lett 1987, 73:197-200.
144. Morris J.C., Price A.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001, 17:101-118.
145. Mortimer J.A. Do psychosocial risk factors contribute to Alzheimer's disease?. Etiology of dementia of Alzheimer's type 1988, Vol. 1:39-52. Wiley, New York.
146. Mufson E.J., Bothwell M., Hersh L.B., Kordower J.H. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J Comp Neurol 1989, 285:196-217.
147. Mufson E.J., Cochran E., Benzing W., Kordower J.H. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome. Dementia 1993, 4:237-250.
148. Mufson E.J., Chen E.Y., Cochran E.J., et al. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol 1999, 158:469-490.
149. Mufson E.J., Deecher D.C., Basile M., Izenwasse S., Mash D.C. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology 2000, 39:1404-1412.
150. Mufson E.J., Ginsberg S.D., Ikonomovic M.D., DeKosky S.T. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 2003, 26(4):233-242.
151. Mufson E.J., Ikonomovic M.D., Styren S.D., Counts S.E., Wuu J., Leurgans S., Bennett D.A., Cochran E.J., DeKosky S.T. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol 2003, 60:1143-1148.
152. Mufson E.J., Counts S.E., Che S., Ginsberg S.D. Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Prog Brain Res 2006, 158:197-223.
153. Mufson E.J., Counts S.E., Perez S.E., Ginsberg S.D. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Expert Rev Neurother 2008, 8:1703-1718.
154. Mufson E.J., He B., Nadeem M., Perez S.E., Counts S.E., Leurgans S., Fritz J., Lah J., Ginsberg S.D., Wuu J., Scheff S.W. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol 2012, 71:1018-1029.
155. Mufson E.J., Binder L., Counts S.E., DeKosky S.T., de Toledo-Morrell L., et al. Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol 2012, 123:13-30.
156. Mufson E.J., He B., Nadeem M., Perez S.E., Counts S.E., Leurgans S., Fritz J., Lah J., Ginsberg S.D., Wuu J., Scheff S.W. Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer's disease. J Neuropathol Exp Neurol 2012, 71:1018-1029.
157. Mufson E.J., Ward S., Binder L. Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer's disease. Neurodegener Dis 2014, 13:151-153.
158. Müller U., Winter P., Graeber M.B. A presenilin 1 mutation in the first case of Alzheimer's disease. Lancet Neurol 2013, 12:129-130.
159. Murphy T.H. Activity-dependent synapse development: changing the rules. Nat Neurosci 2003, 6:9-11.
160. Nadler J.V., Cotman C.W., Lynch G. Histochemical evidence of altered development of cholinergic fibers in the rat dentate gyrus following lesions. I. Time course after complete unilateral entorhinal lesion at various ages. J Comp Neurol 1977, 171:561-587.
161. Nelson P.T., Alafuzoff I., Bigio E.H., Bouras C., Braak H., Cairns N.J., Castellani R.J., Crain B.J., et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol 2012, 71:362-381.
162. Nixon R.A. Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol Aging 2005, 26:373-382.
163. Nixon R.A., Cataldo A.M. The endosomal-lysosomal system of neurons: new roles. Trends Neurosci 1995, 18:489-496.
164. Nixon R.A., Cataldo A.M., Paskevich P.A., Hamilton D.J., Wheelock T.R., Kanaley-Andrews L. The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis. Ann N Y Acad Sci 1992, 674:65-88.
165. Nykjaer A., Lee R., Teng K.K., Jansen P., Madsen P., Nielsen M.S., Jacobsen C., Kliemannel M., Schwarz E., Willnow T.E., Hempstead B.L., Petersen C.M. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427:843-848.
166. Nykjaer A., Willnow T.E., Petersen C.M. P75NTR-live or let die. Curr Opin Neurobiol 2005, 15:49-57.
167. Palmer A.M., Procter A.W., Stratmann G.C., Bowen D.M. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci Lett 1986, 66:199-204.
168. Parton R.G., Dotti C.G. Cell biology of neuronal endocytosis. J Neurosci Res 1993, 36:1-9.
169. Peng S., Wuu J., Mufson E.J., Fahnestock M. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer's disease. J Neuropathol Exp Neurol 2004, 63:641-649.
170. Perez S., Basile M., Mash D.C., Mufson E.J. Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis. J Chem Neuroanat 2002, 24:109-116.
171. Perez S.E., He B., Nadeem M., Wuu J., Ginsberg S.D., Ikonomovic M.D., Mufson E.J. Hippocampal endosomal, lysosomal and autophagic dysregulation in mild cognitive impairment: Correlation with A and tau pathology. JNEN 2015, 74:345-358.
172. Perez-Nievas B.G., Stein T.D., Tai H.C., Dols-Icardo O., Scotton T.C., Barroeta-Espar I., Fernandez-Carballo L., de Munain E.L., Perez J., Marquie M., Serrano-Pozo A., Frosch M.P., Lowe V., Parisi J.E., Petersen R.C., Ikonomovic M.D., López O.L., Klunk W., Hyman B.T., Gómez-Isla T. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology. Brain 2013, 136:2510-2526.
173. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308.
174. Petersen R.C. Mild cognitive impairment clinical trials. Nat Rev Drug Discov 2003, 2:646-653.
175. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999, 45:358-368.
176. Price J.L., McKeel D.W., Buckles V.D., et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009, 30:1026-1036.
177. Procter A.W., Palmer A.M., Francis P.T., Lowe S.L., Neary D., Murphy E., Doshi R., Bowen D.M. Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem 1988, 50:790-802.
178. Ramon y Cajal S. On a special ganglion of the spheno-occipital cortex 1901, Trabajos del Laboratorio de lnvestigaciones Biologicas de la universidad de Madrid, TOMO 1.
179. Reisberg B., Doody R., Stoffler A., Schmitt F., Ferris S., Mobius H.J. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol 2006, 63:49-54.
180. Rodrigues R., Smith M.A., Wang X., Perry G., Lee H.G., Zhu X., Petersen R.B. Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. Future Neurol 2012, 7:287-305.
181. Rodriguez-Puertas R., Nilsson S., Pascual J., Pazos A., Hokfelt T. 125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus. J Neurochem 1998, 68:1106-1113.
182. Rola R., Raber J., Rizk A., Otsuke S., VandenBerg S.R., Morhardt D.R., Fike J.R. Radiation-induced impairment of hippocampal neurogenesis is associated with cognitive deficits in young mice. Exp Neurol 2004, 188:316-330.
183. Roux P.P., Barker P.A. Neurotrophin signaling through the p75 neutrophin receptor. Prog Neurobiol 2002, 67:203-233.
184. Rupp C., Beyreuther K., Maurer K., Kins S. A presenilin 1 mutation in the first case of Alzheimer's disease: revisited. Alzheimers Dement 2014, 10:869-872.
185. Rupsingh R., Borrie M., Smith M., Wells J.L., Bartha R. Reduced hippocampal glutamate in Alzheimer disease. Neurobiol Aging 2011, 32:802-810.
186. Sasaki H., Muramoto O., Kanazawa I., Kosaka K., Iizuka R. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type. Ann Neurol 1986, 19:263-269.
187. Scharfman H.E., Chao M.V. The entorhinal cortex and neurotrophin signaling in Alzheimer's disease and other disorders. Cogn Neurosci 2013, 4:123-135.
188. Scheff S.W., Benardo L.S., Cotman C.W. Decline of reactive fiber growth in the dentate gyrus of aged rats compared to young adult rats following entorhinal cortex removal. Brain Res 1980, 199:21-38.
189. Scheff S.W., DeKosky S.T., Price D.A. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging 1990, 11:29-37.
190. Scheff S.W., Price D.A. Synapse loss in the temporal lobe in Alzheimer's disease. Ann Neurol 1993, 33:190-199.
191. Scheff S.W., Price D.A. Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in alzheimer disease. J Neuropathol Exp Neurol 1998, 57:1146-1153.
192. Scheff S.W., Price D.A. Alzheimer's disease-related synapse loss in the cingulate cortex. J Alzheimers Dis 2001, 3:495-505.
193. Scheff S.W., Price D.A. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging 2003, 24:1029-1046.
194. Scheff S.W., Price D.A. Alzheimer's disease-related alterations in synaptic density: Neocortex and hippocampus. J Alzheimer's Dis 2006, 9:101-115.
195. Scheff S.W., Price D.A., Schmitt F.A., Mufson E.J. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2006, 27:1372-1384.
196. Seiler M., Schwab M.E. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res 1984, 300:33-39.
197. Schneider J.A., Aggarwal N.T., Barnes L., Boyle P., Bennett D.A. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis 2009, 18:691-701.
198. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 1992, 258:126-129.
199. Simonian N.A., Rebeck G.W., Hyman B.T. Functional integrity of neural systems related to memory in Alzheimer's disease. Prog Brain Res 1994, 100:245-254.
200. Smith K.E., Walker M.W., Artymyshyn R., Bard J., Borowsky B., Tamm J.A., Yao W.J., et al. Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J Biol Chem 1998, 273:23321-23326.
201. Snowdon D.A., Gross M.D., Butler S.M. Antioxidants and reduced functional capacity in the elderly: findings from the Nun Study. J Gerontol A Biol Sci Med Sci 1996, 51:M10-M16.
202. Song G., Ouyang G., Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005, 9:59-71.
203. Sperling R., Mormino E., Johnson K. The evolution of preclinical Alzheimer's disease: implications for prevention trials. Neuron 2014, 84:608-622.
204. Steward O., Scoville S.A. Cells of origin of entorhinal cortical afferents to the hippocampus and fascia dentate of the rat. J Comp Neurol 1976, 169:347-370.
205. Steward O., Vinsant S.L. The process of reinnervation in the dentate gyrus of adult rats: a quantitative electron microscopic analysis of terminal proliferation and reactive synaptogenesis. J Comp Neurol 1983, 214:370-386.
206. Stretton J., Sidhu M.K., Winston G.P., Bartlett P., McEvoy A.W., Symms M.R., Koepp M.J., et al. Working memory network plasticity after anterior temporal lobe resection: a longitudinal functional magnetic resonance imaging study. Brain 2014, 137:1439-1453.
207. Stranahan A.M., Mattson M.P. Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plast 2010, 2010:1-8.
208. Sultana R., Banks W.A., Butterfield D.A. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J Neurosci Res 2010, 88:469-477.
209. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol 1997, 56:933-944.
210. Takahashi H., Sekino Y., Tanaka S., Mizui T., Kishi S., Shirao T. Drebrin-dependent actin clustering in dendritic filopodia governs synaptic targeting of postsynaptic density-95 and dendritic spine morphogenesis. J Neurosci 2003, 23:6586-6595.
211. Taylor K.I., Probst A. Anatomic localization of the transentorhinal region of the entorhinal cortex. Neurobiol Aging 2008, 29:1591-1596.
212. Terry R.D., Masliah E., Salmon D.P., et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991, 30:572-580.
213. Thies W., Bleiler L. 2013 Alzheimer's disease facts and figures. Alzheimers Dement 2013, 9:208-245.
214. Thinakaran G., Koo E.H. Amyloid precursor protein trafficking, processing, and function. J Biol Chem 2008, 283:29615-29619.
215. Trojanowski J.Q. The molecular and genetic basis of neurological disease. J Neuropathol Exp Neurol 1993, 52:550.
216. Tu S., Okamoto S., Lipton S.A., Xu H. Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegen 2014, 9:48.
217. Ulrich E., Duwel A., Kauffmann-Zeh A., Lyon D., Rudkin B., Evan G., Martin-Zanca D. Specific TrkA survival signals interfere with different apoptotic pathways. Oncogene 1998, 16:825-832.
218. Vana L., Kanaan N.M., Ugwu I.C., Wuu J., Mufson E.M., Lester I. Progression of tau pathology in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Am J Pathol 2011, 179:2533-2550.
219. Wang J., Xiong S., Xie C., Markesbery W.R., Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005, 93:953-962.
220. Wang Y., Yang R., Gu J., Yin X., Jin N., Xie S., Wang Y., Chang H., Qian W., Shi J., Iqbal K., et al. Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation. Neurobiol Aging 2015, 36:188-200.
221. West M. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol Aging 1993, 14:287-293.
222. West M.J., Kawas C.H., Stewart W.F., Rudow G.L., Troncoso J.C. Hippocampal neurons in pre-clinical Alzheimer' disease. Neurobiol Aging 2004, 25:1205-1212.
223. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., Delong M.R. Alzheimer's disease and senile dementia. Loss of neurons in the basal forebrain. Science 1982, 215:1237-1239.
224. Williams L.R., Varon S., Peterson G.M., Wictorin K., Fischer W., Bjorklund A., Gage F.H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A 1986, 83:9231-9325.
225. Wrenn C.C., Crawley J.N. Pharmacological evidence supporting a role for galanin in cognition and affect. Prog Neuropsychopharmacol Biol Psychiatry 2001, 25:283-299.
226. Wynick D., Bacon A. Targeted disruption of galanin: new insights from knock-out studies. Neuropeptides 2002, 36:132-144.
227. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., et al. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol Dis 2003, 12:97-109.
228. Yasuda R.P., Ikonomovic M.D., Sheffield R., Rubin R.T., Wolfe B.B., Armstrong D.M. Reduction of AMPA-selective glutamate receptor subunits in the entorhinal cortex of patients with Alzheimer's disease pathology: a biochemical study. Brain Res 1995, 678:161-167.
229. Yoshiyama Y., Lee V.M., Trojanowski J.Q. J Therapeutic strategies for tau mediated neurodegeneration. Neurol Neurosurg Psychiatry 2013, 84:784-795.
230. Valdez G., Philippidou P., Rosenbaum J., Akmentin W., Shao Y., Halegoua S. Trk-signaling endosomes are generated by Rac-dependent macroendocytosis. Proc Natl Acad Sci U S A 2007, 104:12270-12275.
231. Vana L., Kanaan N.M., Ugwu I.C., Wuu J., Mufson E.J., Binder L.I. Progression of tau pathology in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Am J Pathol 2011, 179:2533-2550.
232. Vogels O.J., Broere C.A., ter Laak H.J., ten Donkelaar H.J., Nieuwenhuys R., Schulte B.P. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol Aging 1990, 11:3-13.
233. Zarow C., Lyness S.A., Mortimer J.A., Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer' and Parkinson disease. Arch Neurol 2003, 60:337-341.
234. Zheng W., ZhuGe Q., Zhong M., Chen G., Shao B., Wang H., Mao X., Xie L., Jin K. Neurogenesis in adult human brain after traumatic brain injury. J Neurotrauma 2013, 30:1872-1880.